PANAGORA ASSET MANAGEMENT INC - ARRAY BIOPHARMA INC ownership

ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 138 filers reported holding ARRAY BIOPHARMA INC in Q1 2015. The put-call ratio across all filers is 1.02 and the average weighting 0.3%.

Quarter-by-quarter ownership
PANAGORA ASSET MANAGEMENT INC ownership history of ARRAY BIOPHARMA INC
ValueSharesWeighting
Q2 2019$6,306,000
-77.6%
136,133
-88.2%
0.03%
-77.6%
Q1 2019$28,192,000
+120.3%
1,156,356
+28.8%
0.12%
+108.3%
Q4 2018$12,796,000
-27.0%
897,955
-22.1%
0.06%
-9.1%
Q3 2018$17,526,000
-9.9%
1,153,022
-0.5%
0.07%
-14.3%
Q2 2018$19,450,000
+0.9%
1,159,120
-1.8%
0.08%
+1.3%
Q1 2018$19,270,000
+28.0%
1,180,791
+0.4%
0.08%
+33.3%
Q4 2017$15,058,000
-0.1%
1,176,445
-4.0%
0.06%
-5.0%
Q3 2017$15,072,000
+46.1%
1,225,384
-0.6%
0.06%
+42.9%
Q2 2017$10,316,000
-9.3%
1,232,511
-3.2%
0.04%
-10.6%
Q1 2017$11,377,000
+2.8%
1,272,630
+1.0%
0.05%
-7.8%
Q4 2016$11,072,000
+17.7%
1,259,629
-9.6%
0.05%
+13.3%
Q3 2016$9,405,000
+66.1%
1,393,296
-12.4%
0.04%
+60.7%
Q2 2016$5,662,000
+14.5%
1,590,403
-5.1%
0.03%
+12.0%
Q1 2016$4,946,000
+50.0%
1,676,754
+114.6%
0.02%
+56.2%
Q4 2015$3,298,000
-1.1%
781,451
+6.9%
0.02%
-11.1%
Q3 2015$3,333,000
-37.7%
731,071
-1.4%
0.02%
-33.3%
Q2 2015$5,346,000
+16.4%
741,523
+19.0%
0.03%
+17.4%
Q1 2015$4,591,000
+56.1%
623,011
+0.2%
0.02%
+53.3%
Q4 2014$2,941,000
+39.6%
621,867
+5.4%
0.02%
+50.0%
Q3 2014$2,107,000
-25.8%
590,128
-5.2%
0.01%
-28.6%
Q2 2014$2,838,000
+113.2%
622,519
+119.8%
0.01%
+133.3%
Q1 2014$1,331,000
-7.0%
283,164
-0.9%
0.01%
-14.3%
Q4 2013$1,431,000
-22.7%
285,725
-4.0%
0.01%
-22.2%
Q3 2013$1,851,000
+17.9%
297,589
-14.0%
0.01%
+12.5%
Q2 2013$1,570,000346,1300.01%
Other shareholders
ARRAY BIOPHARMA INC shareholders Q1 2015
NameSharesValueWeighting ↓
Redmile Group, LLC 16,459,128$234,543,0009.43%
APIS CAPITAL ADVISORS, LLC 490,000$6,983,0009.36%
BVF INC/IL 4,744,062$67,603,0008.84%
First Light Asset Management, LLC 2,853,826$40,667,0006.48%
SECTORAL ASSET MANAGEMENT INC 2,165,767$30,862,0004.20%
GREAT POINT PARTNERS LLC 1,850,000$26,363,0003.33%
PACIFIC VIEW ASSET MANAGEMENT, LLC 146,952$2,092,0002.46%
Birchview Capital, LP 168,000$2,394,0002.26%
X-Square Capital, LLC 180,554$2,572,0002.02%
FINANCIAL & INVESTMENT MANAGEMENT GROUP LTD 295,610$4,212,0001.54%
View complete list of ARRAY BIOPHARMA INC shareholders